Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person's risk of heart attack, we can intervene earlier and more effectively.

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

Digital health engagement app Wellth raised $36 million in Series C funding to expand its “daily care motivation platform,” ...

Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and ...

Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with ...

Across the U.S., nearly 700 rural hospitals are at risk of closure. When they shut down, the impacts cascade: broken continuity, delayed care, and increased cyber risk in every new system a ...

Employers expect healthcare costs to rise by a median of 9% in 2026, according to a survey by the Business Group on Health. Pharmacy expenses are a key driver.